Category: Finance
Explorers Podcast: Green with envy over GreenTech Metals’ premier Pilbara interests
Stockhead’s ‘Garimpeiro’ columnist Barry FitzGerald is back in the studio for another instalment of The Explorers Podcast. In this episode Barry chats to Thomas Reddicliffe, [more…]
Who are the movers and shakers in Brazil’s burgeoning Lithium Valley?
The state of Minas Gerais is home to Brazil’s booming Lithium Valley ASX juniors are putting their hard rock mining expertise to use in the [more…]
IPO Wrap: Life360 becomes latest ASX company to look at New York listing; and 2 upcoming local IPOs
Blinklab has been the best ASX IPO performer this year Life360 is the latest ASX company to announce plans for a dual listing overseas And [more…]
Bulk Buys: Rio off the freakin’ rails and coal spinoff plans facing pressure from multiple angles
Rio Tinto suffers third derailment in a year But iron ore markets are slow to respond to potential supply disruption with Singapore futures down yesterday [more…]
Mission Critical: Albanese and Chalmers’ budget delivers $7bn splash for critical minerals refiners
Canberra answers miners’ prayers, with $7b production tax credit at centre of $22b Future Made in Australia program The budget announcement could see 10% of [more…]
How the ASX’s Pre-open market works, and the risk of placing an order during this window
ASX traders can place orders when the market is closed We explain how the Pre-open market mechanism works on the ASX And what are the [more…]
Rise and Shine: Everything you need to know before the ASX opens
Good morning everyone, and welcome to 15 May, 2024 – an important day in history of not agreeing with the Catholic Church. That’s because on [more…]
Corella’s on the hunt for pegmatite-hosted critical minerals with airborne survey in the works
An airborne survey is planned to follow up on-ground confirmation of multiple outcropping pegmatites at western Yilgarn tenements The pegmatites have the potential to host [more…]
Blood is thicker this quarter: Morningstar’s pathological outliers. Part 1. Sonic Healthcare
The biomedical treatment of disease and injury is what we call Pathology. Needles. Blood. Tissue. Other gross things. Etc. From the common place lab services [more…]
Long Shortz with AdAlta: Progressive partnership to spread life-saving immunotherapies
Stockhead’s Sarah Hughan sits down with AdAlta (ASX:1AD) CEO and managing director Tim Oldham to get the short end of the long story on the company’s [more…]
